FUND NAME AND TICKER
The fund seeks to deliver superior long-term total returns relative to the MSCI World Health Care Index through active stock selection across the global healthcare sector. Focuses on high-quality companies with strong fundamentals and long-term growth potential.
Invests across the global healthcare sector, including pharmaceuticals, biotechnology, medical devices, and healthcare services, to capture opportunities arising from population aging, rising healthcare demand, and medical innovation.
Relative to the benchmark, the fund maintains a higher allocation to mid-cap biopharma companies, targeting healthcare businesses with strong innovation capabilities and long-term growth potential through a differentiated portfolio positioning.
Invests across global healthcare markets without being limited to a single country or subsector, providing exposure to multinational pharmaceutical companies, innovative biotechnology firms, and leading medical device companies to build a comprehensive healthcare allocation.
TOP HOLDINGS
(as of 30 September 2026)
YEAR TO DATE RETURNS
PRICE CHART
(Source: Bloomberg)
